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Abstract
Background: The high volume of US-Mexico land border crossings can facilitate international 
dissemination of influenza viruses.
Methods: We surveyed adult pedestrians crossing into the United States at two international land 
ports of entry to assess vaccination coverage during the 2009H1N1 influenza pandemic and 2011–
2012 influenza season.
Results: Of 559 participants in 2010, 23.4% reported receipt of the 2009H1N1 vaccine. Of 1423 
participants in 2012, 33.7% received the 2011–2012 influenza vaccine. Both years, those crossing 
the border ≥8 times per month had lower vaccination coverage than those crossing less frequently. 
US-border residents had lower H1N1 coverage than those in other locations. Vaccination coverage 
was higher for persons age ≥65 years and, in 2010 only, those with less than high school 
education. Although most participants believed it is important to get vaccinated, only half believed 
the influenza vaccine was safe and effective. The main reasons for not receiving the influenza 
vaccine were beliefs of low risk of disease, time constraints, and concerns about vaccine safety (in 
2010) or efficacy (in 2012).
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Conclusions: International land border crossers are a large and unique category of travelers that 
require targeted binational strategies for influenza vaccination and education.
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1. Introduction
In 2016, 237 million individuals crossed into the United States from Mexico and Canada 
through official land border ports of entry (POEs), more than double the total number of 
international arrivals by air [1]. The 2000-mile US-Mexico land border is considered the 
world’s busiest international boundary, with 185 million northbound crossings through the 
26 POEs in 2016 [2]. The majority of crossings are by Mexican and US residents of the 
border region traveling regularly to shop, work, or visit family and friends in sister cities 
across the border [3]. Other entrants include tourists and individuals traveling from Mexico 
or other countries to live, work, or seek asylum in the United States [3,4]. The majority of 
crossings are via private vehicles, followed by pedestrians and, least commonly, by 
commercial buses and trains [2]. In addition to authorized border crossers, an estimated 
170,000 entrants crossed by land into the United States in 2016 without authorization 
through areas other than official POEs [5].
The bidirectional flow across the US-Mexico border brings economic, social, and cultural 
benefits to the border region and beyond [3]. However, similarly to air travelers, this 
international movement can facilitate infectious disease dissemination between countries of 
origin, transit, and destination [3]. In addition, frequent border crossers may have close 
social ties in both countries that may increase the risk of cross-border exposure and 
transmission of communicable diseases, such as influenza [6].
Influenza is the most frequent vaccine-preventable disease reported among international 
travelers [7] and creates substantial morbidity and mortality through yearly seasonal 
outbreaks [8]. Novel strains of influenza virus can also cause pandemics, such as the 2009 
influenza A (H1N1) pandemic which, although first detected in a California Southern border 
town, originated in Mexico, and then rapidly spread worldwide, infecting over 200 million 
people [8,9]. Vaccination is the first line of defense against influenza illness and 
transmission [8]. Land border crossers are a population for which the United States and 
Mexico have common interest in ensuring appropriate vaccination levels. Yet published 
information on vaccine uptake in that population is limited. We assessed influenza 
vaccination coverage and attitudes among pedestrian border crossers at US-Mexico land 
POEs during the 2009H1N1 influenza pandemic and 2011–2012 influenza season.
2. Methods
2.1. Study population and sampling design
We conducted two in-person surveys of adult (18 years and older) pedestrians crossing from 
Mexico into the United States at the two busiest land POEs: 1) 2010 survey (March 23–27 
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and April 27–May 10) at San Ysidro (California) and Paso del Norte (Texas) POEs; and 2) 
2012 survey (April 10–23) at San Ysidro POE only. The study protocols were approved by 
the Texas Department of State Health Services, County of San Diego Health and Human 
Services Agency, and US Customs and Border Protection officials. Both surveys received a 
non-research exemption by the US Centers for Disease Control and Prevention.
Systematic random sampling was used to select participants while they waited in line to be 
cleared by US immigration authorities. After an initial “starting person” was randomly 
selected, the interviewer approached each fifth or tenth person in line to confirm age 
eligibility and obtain verbal informed consent. This process allowed interviewers to adjust to 
fluctuations in the length and speed of the pedestrian line and avoid interrupting the 
processing of individuals by immigration authorities. Interviewers were trained bilingual 
public health workers in 2010, and bilingual private survey company staff in 2012. The 
interviews took about 6 min and were conducted in the participant’s preferred language 
(English or Spanish). Recruitment took place at varying times of the day and days of the 
week to capture variations in border crossing flows and characteristics of border crossers. 
The sample size was based on an estimated vaccination coverage of 30%, desired precision 
of ± 4%, and a 95% confidence level, with a goal of a minimum of 505 participants each 
year.
2.2. Data collection tool
In both years, we used a structured survey instrument, which included questions on 
demographics, residence, border crossing frequency, and primary sources of influenza 
prevention information. The 2012 survey had six additional questions on attitudes about 
seasonal influenza and vaccination. Influenza vaccination status was assessed by asking: 
“Have you received a vaccine for H1N1 or swine flu?” (2010 survey) or “Did you happen to 
get a flu shot sometime between August 2011 and today?” (2012 survey). No personally 
identifiable information was collected from respondents. Border region residence (United 
States or Mexico) was defined as living within 62.5 miles north or south of the international 
boundary line [10]. Bilingual staff translated the survey to Spanish. Before use, the 
questionnaires were pilot-tested with members of the target community.
2.3. Data handling and analysis
Data were entered into a database and analyzed using SAS 9.2 (SAS Institute, Cary, NC, 
USA). Chi-square statistical tests were used to assess differences in vaccination coverage 
between the 2010 and 2012 surveys. Extended Mantel-Haenszel chi-square test for linear 
trend was used to assess significant trends in vaccination coverage for ordinal variables (i.e., 
age, education, and border crossing frequency). A p value of < 0.05 was considered 
statistically significant.
3. Results
3.1. Participants
Of 877 pedestrian border crossers approached in 2010, 559 (63.7%) completed the survey 
(282 in Texas and 277 in California); and of 2875 approached in California in 2012, 1423 
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(49.5%) completed the survey. Both years most interviews were completed in Spanish, and 
the majority of participants reported living in the border region, primarily on the Mexican 
side, and crossing the border four or more times a month (Table 1). Compared with 2010, a 
significantly higher percentage of participants in 2012 were 18–37 years old (54.3% vs. 
38.3%, p < 0.001), male (49.4% vs. 41.1%, p < 0.05), and completed at least high school 
education (70.0% vs. 42.5%, p < 0.001).
3.2. Influenza vaccination coverage
In 2010, 23.4% of participants reported having received the H1N1 vaccine (Table 2). Of 
those, 72.7% were vaccinated in Mexico and 27.3% in the United States. In 2012, 33.7% of 
participants reported having received the seasonal influenza vaccine, a significantly higher 
(p < 0.001) percentage than the H1N1 vaccination rate in 2010. Location of vaccination was 
not collected in the 2012 survey. In 2010, vaccination coverage significantly increased 
among participants as frequency of border crossings decreased (p < 0.05). Participants living 
in the US border region had significantly lower H1N1 vaccination coverage than those 
residing on the Mexican side or in non-border locations (18.2% vs. 32.5% vs.33.7%, 
respectively; p < 0.05). In 2012, participants crossing more than 8 times had significantly 
lower vaccination coverage than those crossing 4–7 times per month (p < 0.05), and 
lower(but not significantly) than those crossing less frequently.
Both years, vaccination coverage significantly increased with age of participants (p < 0.05). 
In 2010, higher levels of education completed were significantly associated with lower 
vaccination coverage (p < 0.05), while no significant differences were identified in 2012. 
The most frequently reported primary reason for not having received the influenza vaccine 
varied by survey year. In 2010, “time constraints” was the most frequent reason (17.5%) for 
not being vaccinated against H1N1, followed by believing themselves “not to be at risk for 
influenza illness” (15.0%), concerns about vaccine safety (9.8%), and not being in the 
recommended group for vaccination (7.5%). In 2012, the most frequently reported reasons 
for not having received the seasonal influenza vaccine were believing themselves “not to be 
at risk for influenza illness” (26.8%), concerns about vaccine efficacy (12.5%), “time 
constraints” (4.1%), and cost or not having health insurance (3.3%).
3.3. Sources of information on influenza prevention
Both years, the majority of participants reported mass media, mainly television and radio 
from Mexico, as their primary source of influenza prevention information (Table 3). In 2012, 
compared to 2010, a significantly (p < 0.001) higher percentage of participants received 
influenza information from a doctor (59.5% vs. 14.7%), or from a friend or family member 
(40.5% vs. 4.8%), or saw influenza health messages at a POE (23.0% vs. 5.7%). Also, a 
higher percentage of participants reported not having seen or heard any influenza prevention 
messages in 2012 than in 2010 (35.6% vs. 4.4%).
3.4. Attitudes about seasonal influenza disease and vaccination
In 2012 the majority of participants agreed that seasonal influenza disease is “dangerous” 
(66.9%) and that they (70.6%) or others (81.3%) were likely to catch the disease. Most also 
agreed that it is important to prevent catching (89.7%) and spreading (91.9%) the disease 
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and to get the seasonal influenza vaccine (80.9%). At the same time, fewer participants 
agreed with the statements that the influenza vaccine is safe (50.4%) and prevents catching 
(43.4%) or spreading the influenza virus (50.4%).
4. Discussion
We have shown evidence of influenza vaccination coverage gaps among adults crossing the 
US-Mexico land border. Both the 2009H1N1 and 2011–2012 influenza season had 
vaccination coverages well below the Healthy People 2020 targets at the time of the surveys 
(80% for persons aged 18–64 years and 90% for those aged ≥ 65 years) [11]. The H1N1 
vaccination coverage among border crossers (23.4%) was not significantly different from 
rates reported for non-Hispanic white adults in the United States (23.5%, p > 0.05) [12] and 
for the general population in Mexico (24.8%, p < 0.05) in 2010 [13]. On the other hand, 
although higher than the H1N1 vaccination rate, the 2011–2012 influenza vaccination 
coverage for border crossers (33.7%) was significantly lower than that for adult non-
Hispanic whites (41.9%, p < 0.05), but higher than coverage for Hispanics (29.4%, p < 0.05) 
in the United States [14]. The finding that for both years vaccination coverages were lower 
for the most frequent crossers is of concern because they represented the largest category of 
participants and may have larger cross-border social networks.
In both years the most frequently reported reasons for not receiving the influenza vaccine 
were beliefs of low risk of disease, time constraints, and concerns about the vaccine safety 
(in 2010) or efficacy (in 2012). Low perception of susceptibility to influenza infection and 
negative beliefs about the vaccine’s efficacy and safety have been previously reported, 
among other factors, as significantly associated with lower receipt of the vaccine [15]. In 
2012, a majority of respondents agreed with the importance of vaccination to prevent getting 
and spreading influenza. However, only half or fewer participants believed that the influenza 
vaccine was effective or safe, a smaller percentage than US adults reporting the belief that 
the influenza vaccine is effective (86.6%) or safe (89.3%) [16]. Also, over one-third of 
participants in 2012 reported not having seen or heard any information about seasonal 
influenza prevention.
These findings need to be interpreted keeping in mind the different periods and contexts in 
which the two surveys took place: a) during the last months of an influenza pandemic, and 
b) at the end of an influenza season that was short and mild compared to previous seasons. 
During the H1N1 pandemic, the United States and Mexico launched extraordinary media 
campaigns and other public health interventions to limit the spread of illness [9,17]. 
However, both countries experienced H1Nl vaccine shortages, which were greater in 
Mexico, and different distribution strategies [18]. There were also delays in availability of 
the H1N1 vaccine (October 2009 for the United States and for December 2009 for Mexico), 
with the vaccine being available for the general public when the pandemic was well 
underway [13,16,18]. At the beginning of the pandemic, both countries prioritized similar 
high-risk groups for vaccination, such as pregnant women, infants, the elderly, health care 
personnel, and individuals with chronic diseases. However, during the last months of the 
pandemic, the United States encouraged all residents to get vaccinated, while Mexico 
maintained its priority groups [9,13,19]. In Mexico, the H1N1 vaccine was available for free, 
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mainly at federal government vaccination centers; while in the United States, vaccine 
distribution varied by state and private providers may have collected payments form insured 
patients [18]. Also, for seasonal influenza vaccination, Mexico’s recommendations include 
only prioritized risk groups [19], while in the United States, starting in 2010, vaccination is 
recommended for all individuals more than 6 months old [14]. Our finding of higher H1N1 
vaccination coverage among Mexican border region residents compared to those in the US 
border region, was unexpected, and might have been due to differences between both 
countries in their immunization program strategies and access to vaccinations at the local 
level, and that Mexicans reportedly tended to consider the H1N1 pandemic influenza a more 
serious health threat than US residents did [18].
4.1. Strengths and limitations
The strengths of this assessment included a systematic random sampling of border crossers, 
and data collection by experienced bilingual interviewers, which offered the best chance of 
providing valid findings. The assessment has several limitations. First, lack of information 
on those who refused to participate may have biased our findings if those who chose not to 
participate were systematically different from participants. All information was self-reported 
and thus subject to recall and social desirability bias. Although the surveys were anonymous, 
we do not know whether conducting interviews in an immigration building may have 
influenced participation or responses. The setting allowed for only short questionnaires, and 
thus information on additional factors that may affect vaccination coverage, was not 
collected. Particularly, differences in access to health care and vaccination cost between 
Mexico and the United States, at the national and local levels, may have affected this study 
findings and should be further explored. Differences in the characteristics of crossers 
between 2010 and 2012 and between POEs may have affected the comparability of results. 
The surveys’ findings may not be generalizable to individuals crossing at other land POEs, 
using other transportation modes, or crossing without authorization. In a survey of Mexican 
and other Latin American immigrants planning to cross by land into the United States from 
Tijuana, Mexico, with or without authorization, for work or change of residence, 19% 
reported having received the influenza vaccine in 2013 [20].
4.2. Potential interventions
The land POEs offer efficient locations to implement and evaluate public health 
interventions targeting border crossers, including vaccinations. Stronger collaboration 
between US and Mexican federal and local agencies could enhance land border crossers’ 
access to vaccination and health education. Differences between the countries in influenza 
vaccination recommendations and accessibility would need to be considered. Influenza 
prevention messages can be provided before or after crossing the border and at 
transportation hubs in border towns, for example through large posters and electronic 
boards, or by bilingual health educators or community health workers (or promotoras) [20–
22]. This can be complemented by expanded influenza communication campaigns, in 
Spanish and English, across the border region, using primarily television and radio, plus 
other channels, such as social media, and health care providers.
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Public health interventions might be more effective if tailored to land border crossers’ 
unique characteristics, which differentiate them from international air travelers arriving in 
the United States. These differences include: a) different patterns of travel, such as higher 
frequency, shorter duration, and shorter distance traveled; b) primary purposes for travel 
being most frequently shopping or working (versus tourism or recreation for international air 
travelers); c) closer binational ties, including social networks and frequent exposure to media 
messages in both sides of the border [23–25].
5. Conclusions
Influenza vaccination is an important preventive strategy for travelers in general, whether 
they are crossing nearby borders or visiting other continents [26]. Most international 
travelers arrive to the United States by land, rather than by air or sea [1]. International land 
border crossers are a large and unique category of travelers with high relevance to US-
Mexico and global health, because they can connect remote areas of the world with disparate 
infectious disease burdens [3]. Findings from this assessment suggest the need for further 
implementation and evaluation of targeted public health interventions to address the 
influenza vaccination and information gaps found in this population. Additional assessments 
could provide a better understanding of mobility patterns, health status, access to health 
information, and health-related practices of border crossers along the US-Mexico border. 
Given the transnational nature of border crossers, both countries would benefit from 
enhanced binational collaboration to more effectively protect the health of this population 
and that of communities on both sides of the border. These findings are relevant to other land 
border areas of the world, as demonstrated by the 2014–2015 Ebola outbreak in West Africa, 
when disease spread regionally mostly via ground movement of sick persons across porous 
international land borders [27].
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Table 1
Sociodemographic characteristics of pedestrians crossing international land ports of entry at the US-Mexico 
border, 2010 and 2012.
2010 survey, N in sample (%) 2012 survey, N in sample (%)
Total 559 (100%) 1423 (100%)
Language of interview
 Spanish 505 (90.3) 1316 (92.5)
 English 54 (9.7) 107 (7.5)
Sex*
 Female 329 (58.9) 720 (50.6)
 Male 230 (41.1) 703 (49.4)
Age*
 18–39 years 214 (38.3) 773 (54.3)
 40–64 years 298 (53.1) 588 (41.3)
 65 + years 47 (8.4) 62 (4.4)
Education completed*
 Less than high school 320 (57.4) 426 (29.9)
 High school 113 (20.3) 501 (35.2)
 Some college 74 (13.3) 192 (13.5)
 College degree or more 50 (8.9) 304 (21.3)
Residence*
 US border regiona 141 (25.2) 258 (18.1)
 Mexican border regiona 295 (52.8) 1003 (70.5)
 Other 123 (22.0) 162 (11.4)
Border crossing frequency per month
 8 or more times 231 (41.3) 615 (44.5)
 4–7 times 108 (19.3) 260 (18.8)
 1–3 times 130 (23.3) 304 (21.9)
 Less than 1 time 87 (15.6) 204 (14.8)
*p < 0.05 by chi-square test for comparisons between 2010 and 2012.
a
Border region defined as within 62.5 miles north (United States) or south (Mexico) of the international boundary.
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Table 2
2009H1N1 pandemic influenza and 2001–2012 seasonal influenza vaccination coverage among pedestrians 
crossing international land ports of entry at the US-Mexico border, 2010 and 2012*.
2009 H1N1 influenza vaccination coverage, 2010 2011–2012 seasonal influenza vaccination coverage, 2012
N in sample Vaccination coverage % (95% CI) N in sample Vaccination coverage % (95% CI)
Total* 559 23.4 (20.1–27.1) 1423 33.7 (31.2–36.1)
Language of interview
 Spanish 505 29.9 (25.5–34.4)
(ref.)
1316 33.7 (31.2–36.3)
(ref.)
 English 54 22.7 (10.3–35.2) 107 32.7 (23.8–41.6)
Sex*
 Male 230 23.4 (17.1–29.7)
(ref.)
720 32.2 (28.7–35.6)
(ref.)
 Female 329 32.7 (27.1–38.3) 703 35.1 (31.6–38.6)
Age*
 18–39 years 214 22.3 (16.4–28.3)
(ref.)
773 30.4 (27.1–33.6)
(ref.)
 40–64 years 298 31.9 (25.8–37.9)a 588 36.4 (32.5–40.3)
 65 + years 47 50.0 (33.1–66.9)a 62 48.4 (35.9–60.8)
Education completed*
 Less than high school 320 34.0 (28.1–39.9)
(ref.)
426 39.7 (35.0–44.3)
(ref.)
 High school 113 31.5 (21.8–41.1)a 501 29.5 (25.5–33.5)
 Some college 74 19.4 (9.9–28.9)a 192 30.7 (24.2–37.3)
 College degree or more 50 13.0 (3.3–22.8)a 304 33.9 (28.6–39.2)
Residence*
 US border regionb 141 18.2 (10.9–25.4)(ref.)
258 37.9 (32.1–43.9)
(ref.)
 Mexican border regionb 295 32.5 (26.5–38.4)a 1003 32.2 (29.1–35.1)
 Other 123 33.7 (24.3–43.1)a 162 35.8 (28.4–43.2)
Border crossing frequency per month
 8 or more times 231 21.4 (15.5–27.3)
(ref.)
615 28.6 (25.0–32.0)
(ref.)
 4–7 times 108 28.9 (19.1–38.7)a 260 39.6 (33.7–45.6)a
 1–3 times 130 35.9 (26.6–45.2)a 304 34.9 (29.5–40.2)
 Less than 1 time 87 39.2 (28.0–50.4)a 204 38.7 (32.0–45.4)
*p < 0.05 by chi-square test for comparisons between 2010 and 2012 for each covariate.
ap < 0.05 by chi-square test for comparisons for categories in each variable with the reference group (ref).
b
Border region defined as within 62.5 miles north (United States) or south (Mexico) of the international boundary.
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Table 3
Sources of influenza prevention information among pedestrians crossing international land ports of entry at the 
US-Mexico border, 2010 and 2012a.
Sourceb 2010 survey, All respondents (N = 559) N (%) 2012 survey, All respondents (N = 1423) N (%)
Mass media (television, radio, printed) 476 (85.1) 916 (64.4)
Friends or family 27 (4.8) 576 (40.5)
Health care provider 82 (14.7) 847 (59.5)
Port of entry 32 (5.7) 255 (23.0)
None 24 (4.4) 507 (35.6)
aSurvey respondents could select more than one source of influenza prevention information.
bp < 0.05 by chi-square test for comparisons between 2010 and 2012.
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